Metabolome-derived kidney function scores as prognostic readouts of cardiovascular-kidney-metabolic health.

Kidney disease is a rapidly growing global health concern, tightly linked to cardiovascular and metabolic disease within the recently defined cardiovascular-kidney-metabolic (CKM) syndrome. Routine clinical assessment of kidney function primarily relies on creatinine-based estimated glomerular filtration rates (eGFRcr) which can be affected by non-renal factors and declines only after substantial kidney damage. Using data from the MetaCardis study (N=1,723), we derived metabolomic kidney function gaps (mKFGs)-the difference between metabolome-predicted eGFRcr and measured eGFRcr. A physiology-guided feature-selection strategy - anchored on three cardiometabolic markers (haemoglobin, albumin and the Neutrophil-to-Lymphocyte Ratio) that associate with mKFGs but not with eGFRcr - yielded compact sex-stratified metabolite panels (40-98 out of 1,514 metabolites) that tracked cardiovascular-kidney-metabolic risk. Machine-Learning models revealed distinct metabolic signatures, including biomarkers of meat consumption and androgens, highlighting potential sex-specific pathways linked to CKM health. External validation in the general-population Canadian Longitudinal Study on Aging (N=9,958) and German Chronic Kidney Disease Study (N=5,113) cohorts revealed that mKFGs added incremental predictive value for future CKM events and all-cause mortality beyond eGFRcr and established risk equations. Our findings open new avenues for personalised risk stratification for CKM disease progression and targeted interventions based on metabolically defined kidney health.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-11-10
DOI
https://doi.org/10.64898/2026.11.09.26367636
Primary Topic
Chronic Kidney Disease and Diabetes
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Metabolome-derived kidney function scores as prognostic readouts of cardiovascular-kidney-metabolic health.

Sara Vieira‐Silva, Jeroen Raes, Marc‐Emmanuel Dumas, Janis Marc Nolde et al.
medRxiv
Chronic Kidney Disease and Diabetes
preprint

Metabolome-derived kidney function scores as prognostic readouts of cardiovascular-kidney-metabolic health.

Sara Vieira‐Silva, Jeroen Raes, Marc‐Emmanuel Dumas, Janis Marc Nolde, Trine Nielsen, Francesc Puig‐Castellví, Sofia Kirke Forslund, Kanta Chechi, Karine Clément, Romina Pacheco‐Tapia, Fredrik Bäckhed, Inés Castro, Michael Stümvoll, Eugeni Belda, Jean‐Michel Oppert, Henrik Vestergaard, Oluf Borbye Pedersen, Kai‐Uwe Eckardt, Rima Chakaroun, Gwen Falony, Judith Aron‐Wisnewsky, Peggy Sekula, Julien Chilloux, Matthias Blueher, Emmanuelle Le Chatelier, Jean‐Daniel Zucker, Antonis Myridakis, Manyi Jia, Torben F. Hansen, Philippe Froguel, Petros Andrikopoulos, Christine Rouault, Parminder Raina, Mark G. Lathrop, Angelos Manolias, Elena Butz, Jens Nielsen, Elliot Murphy, Peer Bork, Christine Poitou, Lars Koeber, Anna Koettgen, Pierre Bel Lassen, S. Dusko Ehrlich
preprint en

Abstract

Kidney disease is a rapidly growing global health concern, tightly linked to cardiovascular and metabolic disease within the recently defined cardiovascular-kidney-metabolic (CKM) syndrome. Routine clinical assessment of kidney function primarily relies on creatinine-based estimated glomerular filtration rates (eGFRcr) which can be affected by non-renal factors and declines only after substantial kidney damage. Using data from the MetaCardis study (N=1,723), we derived metabolomic kidney function gaps (mKFGs)-the difference between metabolome-predicted eGFRcr and measured eGFRcr. A physiology-guided feature-selection strategy - anchored on three cardiometabolic markers (haemoglobin, albumin and the Neutrophil-to-Lymphocyte Ratio) that associate with mKFGs but not with eGFRcr - yielded compact sex-stratified metabolite panels (40-98 out of 1,514 metabolites) that tracked cardiovascular-kidney-metabolic risk. Machine-Learning models revealed distinct metabolic signatures, including biomarkers of meat consumption and androgens, highlighting potential sex-specific pathways linked to CKM health. External validation in the general-population Canadian Longitudinal Study on Aging (N=9,958) and German Chronic Kidney Disease Study (N=5,113) cohorts revealed that mKFGs added incremental predictive value for future CKM events and all-cause mortality beyond eGFRcr and established risk equations. Our findings open new avenues for personalised risk stratification for CKM disease progression and targeted interventions based on metabolically defined kidney health.

medRxiv
University of Copenhagen (DK), University of Freiburg (DE), Johannes Gutenberg University Mainz (DE), Max Delbrück Center (DE), Université de Lille (FR), Université Paris-Saclay (FR), Sorbonne Université (FR), European Molecular Biology Laboratory (DE), European Molecular Biology Laboratory (DE), University College London (GB), Imperial College London (GB), McGill University (CA), Chalmers University of Technology (SE), Charité - Universitätsmedizin Berlin (DE), University of Gothenburg (SE), Wageningen University & Research (NL), Leipzig University (DE), McMaster University (CA), KU Leuven (BE)
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon